关键词：纳米技术；纳米机器人；医疗保健；纳米医学
摘 要：Nanotechnology is a field of science that helps in controlling matter on an atomic and molecular scale. In other words, technology used at the scale of one-billionth of a meter is referred to as nanotechnology. Over the years, nanotechnology has received much attention because of its potential to revolutionize each field in which it is used. In the recent past, nanotechnology has made a significant impact on pharmaceutical drug delivery. Nanomedicines and related products are used to control molecular structures of human cells for more effective diagnosis and treatments.The Global Nanomedicine market is expected to grow at a rapid pace during the period 2012-2016. In 2012, the Americascontributed the highest to the revenue of the Global Nanomedicine market, and it was followed by the EMEA region. Although the APAC region holds the least market share, certain countries in the APAC region, such asJapan, offer significant growth opportunities to the market. Moreover, there is a substantial demand for healthcare facilities, nanomedicines, and treatments inChinaandIndiaas these are the most populated countries in the world and thus have a large number of patients. Further, the rapid growth of the market in developing countries is expected to lead to an increase in new nanomedicine development. Overall, the market is expected to grow at a CAGR of 12.57 percent during the forecast period.
目 录：01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Global Nanotechnology Market

Market Overview

06.2 Global Nanomedicine Market

Market Size and Forecast

06.3 Five Forces Analysis

07. Key Market Segmentation

07.1 Segmentation by Application

Global Nanomedicine Market by Application Types 2012

Global Nanomedicine Market by Application Types 2012-2016

07.2 Global Nanomedicine Market in Anticancer Segment

Market Size and Forecast

07.3 Global Nanomedicine Market in CNS Products Segment

Market Size and Forecast

07.4 Global Nanomedicine Market in Anti-infective Segment

Market Size and Forecast

07.5 Global Nanomedicine Market in Anti-inflammatory Segment

Market Size and Forecast

07.6 Global Nanomedicine Market in Cardiovascular Segment

Market Size and Forecast

07.7 Global Nanomedicine Market in Others Segment

Market Size and Forecast

08. Geographical Segmentation

09. Key Leading Countries

USA

Germany

Japan

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis

17.1 Abbott Laboratories

Business Overview

Business Segmentation

Key Information

SWOT Analysis

17.2 AstraZeneca plc

Business Overview

Business Segmentation

Key Information

SWOT Analysis

17.3 Bristol-Myers Squibb Co.

Business Overview

Business Segmentation

Key Information

SWOT Analysis

17.4 Celgene Corp.

Business Overview

Business Segmentation

Key Information

SWOT Analysis

17.5 GlaxoSmithKline plc

Business Overview

Business Segmentation

Key Information

SWOT Analysis

17.6 Pfizer Inc.

Business Overview

Business Segmentation

Key Information

SWOT Analysis

18. Other Reports in this Series